Literature DB >> 9443865

A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease.

C Tysoe1, J Whittaker, J Xuereb, N J Cairns, M Cruts, C Van Broeckhoven, G Wilcock, D C Rubinsztein.   

Abstract

We have examined genomic DNA from 40 cases of autopsy-confirmed early-onset Alzheimer disease (EOAD) (age at onset <=65 years) that were all unselected for family history. We have sequenced the 10 exons and flanking intronic sequences of the presenilin-1 (PS-1) gene for all 40 individuals. A single mutation, a deletion of a G from the intron 4 splice-donor consensus sequence, was detected in two individuals in this study. The mutation was associated with two shortened transcripts, both with shifted reading frames resulting in premature-termination codons. All the PS-1 mutations described elsewhere have been missense or in-frame splice mutations, and recent data suggest that these result in disease by gain-of-function or dominant-negative mechanisms. The mutation that we have identified is likely to result in haploinsufficiency and would be most consistent with other mutations acting in a dominant-negative manner. However, we cannot exclude the possibility that the small amounts of truncated transcripts exert a gain of function. Since no other mutations or polymorphisms were detected in our patients, mutations in the coding regions and splice consensus sequences of PS-1 are likely to be rare in EOAD cases unselected for family history.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9443865      PMCID: PMC1376799          DOI: 10.1086/301672

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

1.  Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation.

Authors:  M N Rossor; N C Fox; J Beck; T C Campbell; J Collinge
Journal:  Lancet       Date:  1996-06-01       Impact factor: 79.321

2.  Defects in RNA splicing and the consequence of shortened translational reading frames.

Authors:  L E Maquat
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

3.  A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene.

Authors:  J Perez-Tur; S Froelich; G Prihar; R Crook; M Baker; K Duff; M Wragg; F Busfield; C Lendon; R F Clark
Journal:  Neuroreport       Date:  1995-12-29       Impact factor: 1.837

4.  A catalogue of splice junction sequences.

Authors:  S M Mount
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

5.  Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

Authors:  D Scheuner; C Eckman; M Jensen; X Song; M Citron; N Suzuki; T D Bird; J Hardy; M Hutton; W Kukull; E Larson; E Levy-Lahad; M Viitanen; E Peskind; P Poorkaj; G Schellenberg; R Tanzi; W Wasco; L Lannfelt; D Selkoe; S Younkin
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

6.  Analysis of alpha-1 antichymotrypsin, presenilin-1, angiotensin-converting enzyme, and methylenetetrahydrofolate reductase loci as candidates for dementia.

Authors:  C Tysoe; D Galinsky; D Robinson; C E Brayne; D F Easton; F A Huppert; T Dening; E S Paykel; D C Rubinsztein
Journal:  Am J Med Genet       Date:  1997-04-18

7.  Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group.

Authors:  M Wragg; M Hutton; C Talbot
Journal:  Lancet       Date:  1996-02-24       Impact factor: 79.321

Review 8.  Molecular genetics of Alzheimer disease: identification of genes and gene mutations.

Authors:  C L Van Broeckhoven
Journal:  Eur Neurol       Date:  1995       Impact factor: 1.710

9.  Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3.

Authors:  M Cruts; H Backhovens; S Y Wang; G Van Gassen; J Theuns; C D De Jonghe; A Wehnert; J De Voecht; G De Winter; P Cras
Journal:  Hum Mol Genet       Date:  1995-12       Impact factor: 6.150

10.  Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease.

Authors:  M Hutton; F Busfield; M Wragg; R Crook; J Perez-Tur; R F Clark; G Prihar; C Talbot; H Phillips; K Wright; M Baker; C Lendon; K Duff; A Martinez; H Houlden; A Nichols; E Karran; G Roberts; P Roques; M Rossor; J C Venter; M D Adams; R T Cline; C A Phillips; A Goate
Journal:  Neuroreport       Date:  1996-02-29       Impact factor: 1.837

View more
  17 in total

1.  Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.

Authors:  Suman Jayadev; James B Leverenz; Ellen Steinbart; Justin Stahl; William Klunk; Cheng-En Yu; Thomas D Bird
Journal:  Brain       Date:  2010-04       Impact factor: 13.501

Review 2.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

3.  Founder effect for the Ala431Glu mutation of the presenilin 1 gene causing early-onset Alzheimer's disease in Mexican families.

Authors:  Petra Yescas; Adriana Huertas-Vazquez; María Teresa Villarreal-Molina; Astrid Rasmussen; María Teresa Tusié-Luna; Marisol López; Samuel Canizales-Quinteros; María Elisa Alonso
Journal:  Neurogenetics       Date:  2006-04-21       Impact factor: 2.660

4.  Linkage detection adaptive to linkage disequilibrium: the disequilibrium maximum-likelihood-binomial test for affected-sibship data.

Authors:  J Huang; Y Jiang
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

Review 5.  Tailoring of membrane proteins by alternative splicing of pre-mRNA.

Authors:  Kathleen F Mittendorf; Catherine L Deatherage; Melanie D Ohi; Charles R Sanders
Journal:  Biochemistry       Date:  2012-06-29       Impact factor: 3.162

6.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.

Authors:  D Campion; C Dumanchin; D Hannequin; B Dubois; S Belliard; M Puel; C Thomas-Anterion; A Michon; C Martin; F Charbonnier; G Raux; A Camuzat; C Penet; V Mesnage; M Martinez; F Clerget-Darpoux; A Brice; T Frebourg
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

7.  Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation.

Authors:  A C Bruni; L Bernardi; R Colao; E Rubino; N Smirne; F Frangipane; B Terni; S A M Curcio; M Mirabelli; A Clodomiro; R Di Lorenzo; R Maletta; M Anfossi; M Gallo; S Geracitano; C Tomaino; M G Muraca; A Leotta; S G Lio; L Pinessi; I Rainero; S Sorbi; L Nee; G Milan; S Pappatà; A Postiglione; N Abbamondi; G Forloni; P St George Hyslop; E Rogaeva; O Bugiani; G Giaccone; J F Foncin; M G Spillantini; G Puccio
Journal:  Neurology       Date:  2010-02-17       Impact factor: 9.910

Review 8.  Sequence analyses of presenilin mutations linked to familial Alzheimer's disease.

Authors:  Sun Don Kim; Jinoh Kim
Journal:  Cell Stress Chaperones       Date:  2008-05-20       Impact factor: 3.667

9.  Presenilin 2 is the predominant γ-secretase in microglia and modulates cytokine release.

Authors:  Suman Jayadev; Amanda Case; Alison J Eastman; Huy Nguyen; Julia Pollak; Jesse C Wiley; Thomas Möller; Richard S Morrison; Gwenn A Garden
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

Review 10.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.